Ludovic Caillo

945 total citations
25 papers, 132 citations indexed

About

Ludovic Caillo is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Ludovic Caillo has authored 25 papers receiving a total of 132 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 13 papers in Surgery and 13 papers in Epidemiology. Recurrent topics in Ludovic Caillo's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (10 papers) and Esophageal and GI Pathology (6 papers). Ludovic Caillo is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (10 papers) and Esophageal and GI Pathology (6 papers). Ludovic Caillo collaborates with scholars based in France, Belgium and India. Ludovic Caillo's co-authors include Mathurin Fuméry, Guillaume Bouguen, Romain Altwegg, Marc Barthet, Jean‐Michel Gonzalez, Aurélien Amiot, Laurent Peyrin‐Biroulet, Lucine Vuitton, Mélanie Serrero and Stéphane Nancey and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Ludovic Caillo

20 papers receiving 129 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ludovic Caillo France 6 83 79 61 28 25 25 132
Animesh Jain United States 7 112 1.3× 74 0.9× 102 1.7× 30 1.1× 14 0.6× 15 194
Matteo Porta Italy 5 36 0.4× 94 1.2× 65 1.1× 78 2.8× 16 0.6× 12 167
Dedrick E. Moulton United States 6 53 0.6× 66 0.8× 36 0.6× 15 0.5× 6 0.2× 11 118
Caroline Trang-Poisson France 4 60 0.7× 46 0.6× 37 0.6× 32 1.1× 13 0.5× 10 92
My‐Linh Tran‐Minh France 5 116 1.4× 87 1.1× 89 1.5× 8 0.3× 18 0.7× 12 162
Maria Teresa Illiceto Italy 8 56 0.7× 90 1.1× 42 0.7× 7 0.3× 13 0.5× 16 135
Monica Muraca Italy 5 92 1.1× 54 0.7× 59 1.0× 5 0.2× 4 0.2× 16 145
Luca Ferraris Italy 5 163 2.0× 74 0.9× 128 2.1× 34 1.2× 5 0.2× 10 213
James Izanec United States 7 90 1.1× 59 0.7× 67 1.1× 26 0.9× 2 0.1× 23 128
Sara Campos Portugal 7 34 0.4× 37 0.5× 79 1.3× 4 0.1× 13 0.5× 14 146

Countries citing papers authored by Ludovic Caillo

Since Specialization
Citations

This map shows the geographic impact of Ludovic Caillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludovic Caillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludovic Caillo more than expected).

Fields of papers citing papers by Ludovic Caillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ludovic Caillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludovic Caillo. The network helps show where Ludovic Caillo may publish in the future.

Co-authorship network of co-authors of Ludovic Caillo

This figure shows the co-authorship network connecting the top 25 collaborators of Ludovic Caillo. A scholar is included among the top collaborators of Ludovic Caillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ludovic Caillo. Ludovic Caillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buisson, Anthony, Maria Nachury, Mathieu Uzzan, et al.. (2025). P0611 Effectiveness comparisons between tofacitinib, filgotinib and upadacitinib in ulcerative colitis: results from the JAKARTA real-world evidence multicenter study. Journal of Crohn s and Colitis. 19(Supplement_1). i1211–i1211.
2.
Buisson, Anthony, Laurent Peyrin‐Biroulet, Gilles Boschetti, et al.. (2025). P0649 Acceptability and Tolerance of Risankizumab Treatment Administered via On-Body Injector in Patients with Crohn’s Disease: Results of the Nationwide ACCEPT-OBI Study. Journal of Crohn s and Colitis. 19(Supplement_1). i1274–i1274. 1 indexed citations
3.
Rivière, Pauline, Romain Altwegg, Ludovic Caillo, et al.. (2025). Safety of Advanced Combination Treatment With Selective JAK1 Inhibitors and Biological Therapies in Inflammatory Bowel Diseases: A Real World Experience. Alimentary Pharmacology & Therapeutics. 61(10). 1692–1696.
4.
Camus, Marine, Geoffroy Vanbiervliet, Robert Benamouzig, et al.. (2025). Prospective assessment of learning curve and impact of intensive versus progressive training in colonoscopy competence among French residents. BMC Medical Education. 25(1). 367–367.
5.
6.
7.
Fuméry, Mathurin, Mélanie Serrero, Guillaume Bouguen, et al.. (2024). Real-World Comparison of the Effectiveness between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at least One Anti-TNF Agent. Journal of Crohn s and Colitis. 18(10). 1615–1621. 8 indexed citations
8.
9.
Nancey, Stéphane, Mélanie Serrero, Ludovic Caillo, et al.. (2023). Risk of infection in elderly patients with inflammatory bowel disease under biologics: A prospective, multicenter, observational, one-year follow-up comparative study. Clinics and Research in Hepatology and Gastroenterology. 47(5). 102107–102107. 3 indexed citations
10.
Buisson, Anthony, Mélanie Serrero, Romain Altwegg, et al.. (2023). P579 Real-world comparison of effectiveness between tofacitinib and ustekinumab in patients with ulcerative colitis exposed to at least one anti-TNF agent: results from the TORUS study. Journal of Crohn s and Colitis. 17(Supplement_1). i707–i707. 2 indexed citations
11.
Chambrun, Guillaume Pineton de, Benjamin Lallemant, R. Garrel, et al.. (2023). Management of the Zenker diverticulum: multicenter retrospective comparative study of open surgery and rigid endoscopy versus flexible endoscopy. Surgical Endoscopy. 37(9). 7064–7072. 2 indexed citations
12.
Prost, Audrey, Benjamin Louart, Ludovic Caillo, et al.. (2023). Echocardiographic hemodynamic assessment in decompensated cirrhosis: comparison between Intensivists and Gastroenterologists. Journal of Clinical Monitoring and Computing. 37(5). 1219–1228.
13.
Amiot, Aurélien, Delphine Gaye, Nora Frulio, et al.. (2023). Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn’s Disease: A Multicentre Case-Control Study. Cancers. 15(7). 2004–2004. 2 indexed citations
14.
Buisson, Anthony, Mélanie Serrero, Romain Altwegg, et al.. (2023). 14 REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS EXPOSED TO AT LEAST ONE ANTI-TNF AGENT: RESULTS FROM THE TORUS STUDY. Gastroenterology. 164(6). S–4. 1 indexed citations
15.
Buisson, Anthony, Maria Nachury, Romain Altwegg, et al.. (2022). Real‐world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti‐TNF agent. Alimentary Pharmacology & Therapeutics. 57(6). 676–688. 15 indexed citations
16.
Gonzalez, Jean‐Michel, et al.. (2022). Training in esophageal peroral endoscopic myotomy (POEM) on an ex vivo porcine model: learning curve study and training strategy. Surgical Endoscopy. 37(3). 2062–2069. 2 indexed citations
17.
Serrero, Mélanie, Ludovic Caillo, Cyrielle Gilletta, et al.. (2022). P604 Infection Risk in Elderly Patients with Inflammatory Bowel Disease under anti-TNF, ustekinumab or vedolizumab biologic therapies: A Prospective Multicenter observational One-Year follow-up comparative study. Journal of Crohn s and Colitis. 16(Supplement_1). i537–i537. 1 indexed citations
18.
Gonzalez, Jean‐Michel, et al.. (2020). Per-oral endoscopic myotomy with septotomy for the treatment of distal esophageal diverticula (D-POEM). Surgical Endoscopy. 34(5). 2321–2325. 23 indexed citations
19.
Rivière, Pauline, Stéphane Nancey, Xavier Roblin, et al.. (2020). Comparative efficacy and safety of vedolizumab and infliximab in ulcerative colitis after failure of a first subcutaneous anti‐TNF agent: a multicentre cohort study. Alimentary Pharmacology & Therapeutics. 51(9). 852–860. 31 indexed citations
20.
Attar, A., Julien Branche, Emmanuel Coron, et al.. (2017). P608 New anti-migration extractible metal stents for Crohn's disease strictures: a nationwide GETAID-SFED cohort study. Journal of Crohn s and Colitis. 11(suppl_1). S389–S390. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Animesh Jain Breakdown of academic impact, for papers by Matteo Porta Breakdown of academic impact, for papers by Dedrick E. Moulton Breakdown of academic impact, for papers by Caroline Trang-Poisson Breakdown of academic impact, for papers by My‐Linh Tran‐Minh Breakdown of academic impact, for papers by Maria Teresa Illiceto Breakdown of academic impact, for papers by Monica Muraca Breakdown of academic impact, for papers by Luca Ferraris Breakdown of academic impact, for papers by James Izanec Breakdown of academic impact, for papers by Sara Campos
Rankless by CCL
2026